Anticholinergic Medications and Cognitive Function in Late Midlife.

Anticholinergic Medications and Cognitive Function in Late Midlife. Alzheimer Dis Assoc Disord. 2018 Feb 23;: Authors: Limback-Stokin MM, Krell-Roesch J, Roesler K, Hansen A, Stonnington CM, Temkit M, Caselli RJ, Geda YE PMID: 29481373 [PubMed - as supplied by publisher]
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research

Related Links:

Analyst, 2018, Accepted Manuscript DOI: 10.1039/C8AN00804C, PaperNatalie Schwenk, Boris Mizaikoff, Soledad C árdenas, Ángela I. López-Lorente Aggregation of proteins has been related to some neurodegenerative diseases such as Alzheimer, and Parkinson among others. Raman spectroscopy is a useful technique for the investigation of protein conformation, and... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Joana R. Guedes, Taotao Lao, Ana L. Cardoso, Joseph El Khoury
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Publication date: August 2018Source: Alzheimer's &Dementia, Volume 14, Issue 8Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: August 2018Source: Alzheimer's &Dementia, Volume 14, Issue 8Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: August 2018Source: Alzheimer's &Dementia, Volume 14, Issue 8Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: August 2018Source: Alzheimer's &Dementia, Volume 14, Issue 8Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: August 2018Source: Alzheimer's &Dementia, Volume 14, Issue 8Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: Available online 13 August 2018Source: Stem Cell ResearchAuthor(s): Sonia Sanz Muñoz, Rachelle Balez, Mauricio e Castro Cabral-da-Silva, Tracey Berg, Martin Engel, Monique Bax, Dzung Do-Ha, Claire H. Stevens, Mark Greenough, Ashley Bush, Lezanne OoiAbstractThe induced pluripotent stem cell (iPSC) lines UOWi002-A and UOWi003-A were reprogrammed from dermal fibroblasts via mRNA transfection. Dermal fibroblasts from a 56 year old female caucasian familial Alzheimer's disease patient carrying A246E mutation in the PSEN1 gene (familial AD3, autopsy confirmed Alzheimer's disease) and a 75 year old fe...
Source: Stem Cell Research - Category: Stem Cells Source Type: research
(Boston University School of Medicine) Researchers have discovered new genes that will further current understanding of the genetic risk factors that predispose people to the development of Alzheimer's disease (AD).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Molecules, Vol. 23, Pages 2033: Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease Molecules doi: 10.3390/molecules23082033 Authors: Weiam Hussein Begüm Nurpelin Sağlık Serkan Levent Büşra Korkut Sinem Ilgın Yusuf Özkay Zafer Asım Kaplancıklı Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and causes death due to dementia. The main pathogenic feature connected with the progression of this multifactorial disease is the weakening of the cholinergic system in the brain. Cholinesterase (C...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research
More News: Alzheimer's | Psychiatry